These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 21569069

  • 1. Anaphylaxis during the first course of high-dose methotrexate: a case report and literature review.
    Pugi A, Benemei S, Vietri M, Tondo A, Calvani AM, Mugelli A, Vannacci A, Lapi F.
    J Clin Pharm Ther; 2012 Apr; 37(2):245-8. PubMed ID: 21569069
    [Abstract] [Full Text] [Related]

  • 2. Anaphylactoid reaction to high-dose methotrexate and successful desensitization.
    Oulego-Erroz I, Maneiro-Freire M, Bouzón-Alejandro M, Vázquez-Donsión M, Couselo JM.
    Pediatr Blood Cancer; 2010 Sep; 55(3):557-9. PubMed ID: 20533520
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Delayed renal excretion of methotrexate after a severe anaphylactic reaction to methotrexate in a child with osteosarcoma.
    Ozguven AA, Uysal K, Gunes D, Koroglu T, Gurcu O, Olgun N.
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):289-91. PubMed ID: 19346884
    [Abstract] [Full Text] [Related]

  • 5. Successful desensitization to high-dose methotrexate after systemic anaphylaxis.
    Davis KA, Williams P, Walker JC.
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):87-9. PubMed ID: 12546343
    [Abstract] [Full Text] [Related]

  • 6. Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.
    Müller J, Kralovánszky J, Adleff V, Pap E, Németh K, Komlósi V, Kovács G.
    Anticancer Res; 2008 Jan; 28(5B):3051-4. PubMed ID: 19031955
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
    Nowicki TS, Bjornard K, Kudlowitz D, Sandoval C, Jayabose S.
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):950-2. PubMed ID: 19131789
    [Abstract] [Full Text] [Related]

  • 9. [A case of subacute transient cerebral dysfunction in a osteosarcoma patient following high-dose methotrexate].
    Yamada K, Takahashi M, Yoshida M.
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):469-72. PubMed ID: 11915742
    [Abstract] [Full Text] [Related]

  • 10. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC.
    Cancer; 2004 May 15; 100(10):2222-32. PubMed ID: 15139068
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of severe side effects of high-dose methotrexate in osteosarcoma].
    Umeda T, Takada N, Hodaka E, Endoh F, Ishii T.
    Gan To Kagaku Ryoho; 1984 Feb 15; 11(2):285-94. PubMed ID: 6582805
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Variability in dose intensity of high-dose methotrexate for nonmetastatic osteosarcoma.
    Leavey PJ, Mantadakis E, Maale G.
    Pediatr Hematol Oncol; 2002 Feb 15; 19(7):483-9. PubMed ID: 12217194
    [Abstract] [Full Text] [Related]

  • 16. Effective removal of methotrexate by high-flux hemodialysis.
    Saland JM, Leavey PJ, Bash RO, Hansch E, Arbus GS, Quigley R.
    Pediatr Nephrol; 2002 Oct 15; 17(10):825-9. PubMed ID: 12376811
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate levels and outcome in osteosarcoma.
    Zelcer S, Kellick M, Wexler LH, Shi W, Sankaran M, Lo S, Healey J, Huvos AG, Meyers PA, Gorlick R.
    Pediatr Blood Cancer; 2005 Jun 15; 44(7):638-42. PubMed ID: 15704189
    [Abstract] [Full Text] [Related]

  • 18. Outpatient high-dose methotrexate: proceed with extreme caution, if at all.
    Womer RB.
    Pediatr Blood Cancer; 2010 Dec 15; 55(7):1250-1. PubMed ID: 20981687
    [No Abstract] [Full Text] [Related]

  • 19. Drug-drug interaction between methotrexate and levetiracetam resulting in delayed methotrexate elimination.
    Bain E, Birhiray RE, Reeves DJ.
    Ann Pharmacother; 2014 Feb 15; 48(2):292-6. PubMed ID: 24259648
    [Abstract] [Full Text] [Related]

  • 20. Acute transient cerebral toxicity associated with administration of high-dose methotrexate.
    Mittal R, Mottl H, Nemec J.
    Med Princ Pract; 2005 Feb 15; 14(3):202-4. PubMed ID: 15863997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.